MEROLA, Aristide
 Distribuzione geografica
Continente #
EU - Europa 1.771
NA - Nord America 1.668
AS - Asia 673
OC - Oceania 94
SA - Sud America 82
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 6
Totale 4.326
Nazione #
US - Stati Uniti d'America 1.568
DE - Germania 522
IT - Italia 478
CN - Cina 230
GB - Regno Unito 185
JP - Giappone 154
IN - India 92
AU - Australia 88
CA - Canada 86
FR - Francia 86
ES - Italia 78
NL - Olanda 67
RO - Romania 50
BR - Brasile 40
KR - Corea 39
PL - Polonia 36
CZ - Repubblica Ceca 33
TR - Turchia 27
CH - Svizzera 26
PT - Portogallo 22
RU - Federazione Russa 20
SE - Svezia 18
AT - Austria 17
ID - Indonesia 17
VN - Vietnam 17
ZA - Sudafrica 17
GR - Grecia 16
HK - Hong Kong 16
IE - Irlanda 16
AR - Argentina 15
BE - Belgio 15
CL - Cile 15
TW - Taiwan 14
IL - Israele 13
PH - Filippine 13
DK - Danimarca 12
EG - Egitto 11
CO - Colombia 10
MX - Messico 10
IS - Islanda 9
FI - Finlandia 8
UA - Ucraina 8
IR - Iran 7
BG - Bulgaria 6
MY - Malesia 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
SA - Arabia Saudita 6
EU - Europa 5
HR - Croazia 5
RS - Serbia 5
SI - Slovenia 5
LT - Lituania 4
SG - Singapore 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
HU - Ungheria 3
JO - Giordania 3
MT - Malta 3
EC - Ecuador 2
GE - Georgia 2
MA - Marocco 2
NG - Nigeria 2
PK - Pakistan 2
PR - Porto Rico 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GI - Gibilterra 1
IQ - Iraq 1
KZ - Kazakistan 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
Totale 4.326
Città #
Houston 148
Torino 134
Fairfield 128
Ann Arbor 94
Seattle 74
Ashburn 71
Woodbridge 67
Buffalo 64
Cambridge 60
Beijing 53
Santa Cruz 49
Wilmington 42
Nürnberg 38
Hangzhou 30
Shanghai 30
Tokyo 30
Sydney 26
London 24
University Park 23
Toronto 21
Duncan 20
Rome 19
Leawood 18
Mountain View 18
Wuhan 18
Chicago 16
Las Vegas 15
Milan 15
Madrid 14
Turin 14
Lyon 13
Taipei 13
Bengaluru 11
Columbia 11
Dublin 11
Jakarta 11
Los Angeles 11
Ottawa 11
Zhengzhou 11
Barcelona 10
Dong Ket 10
Warsaw 10
Clearwater 9
Madison 9
Minneapolis 9
New York 9
Phoenix 9
Würzburg 9
Bethlehem 8
Denver 8
Guangzhou 8
Paris 8
Santiago 8
Baulkham Hills 7
Copenhagen 7
Edinburgh 7
Fleming Island 7
Huntington Station 7
Lake Forest 7
Melbourne 7
Muizenberg 7
Saint Paul 7
Teresina 7
Boardman 6
Buenos Aires 6
Central District 6
Delhi 6
Fukuoka 6
Hanoi 6
L’Aquila 6
Medellín 6
Napoli 6
Nashville 6
Oxford 6
Polska 6
Quezon City 6
Rochester 6
Seoul 6
Shrewsbury 6
Thirsk 6
Toulouse 6
Valencia 6
Austin 5
Brooklyn 5
Cincinnati 5
Columbus 5
Dallas 5
Easton 5
Helsinki 5
Hyderabad 5
Istanbul 5
Kraków 5
Lawrence 5
Mumbai 5
Pisa 5
Québec 5
Salt Lake City 5
San Mauro Torinese 5
Valdemolinos 5
Venezia 5
Totale 1.874
Nome #
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease?, file e27ce426-f5b7-2581-e053-d805fe0acbaa 538
Levodopa-carbidopa intestinal gel infusion and weight loss in Parkinson's disease, file e27ce42d-4f11-2581-e053-d805fe0acbaa 512
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study., file e27ce427-0f2e-2581-e053-d805fe0acbaa 492
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience, file e27ce426-fc98-2581-e053-d805fe0acbaa 491
Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study, file e27ce426-fafb-2581-e053-d805fe0acbaa 345
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients., file e27ce426-f234-2581-e053-d805fe0acbaa 258
Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients., file e27ce426-d803-2581-e053-d805fe0acbaa 255
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease, file e27ce42b-4ddc-2581-e053-d805fe0acbaa 250
Short-term efficacy of ultramicronized palmitoylethanolamide in peripheral neuropathic pain., file e27ce426-f508-2581-e053-d805fe0acbaa 191
Personality and Deep Brain Stimulation of the subthalamic nucleus in Parkinson's disease, file e27ce426-f341-2581-e053-d805fe0acbaa 188
Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation?, file e27ce427-0eaa-2581-e053-d805fe0acbaa 185
Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients, file e27ce426-fafc-2581-e053-d805fe0acbaa 158
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome?, file e27ce426-fa3d-2581-e053-d805fe0acbaa 127
Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study., file e27ce426-d9a8-2581-e053-d805fe0acbaa 116
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: effects on involuntary movements., file e27ce426-e613-2581-e053-d805fe0acbaa 90
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset?, file e27ce426-dbf5-2581-e053-d805fe0acbaa 87
Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside, file e27ce42d-2dc2-2581-e053-d805fe0acbaa 79
Machine learning applied to ambulatory blood pressure monitoring: a new tool to diagnose autonomic failure?, file e27ce435-99c7-2581-e053-d805fe0acbaa 12
Earlier versus later subthalamic deep brain stimulation in Parkinson's disease, file e27ce427-c97f-2581-e053-d805fe0acbaa 9
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: effects on involuntary movements., file e27ce426-e612-2581-e053-d805fe0acbaa 7
Burden of caregiving for cardiovascular dysautonomia in Parkinson's disease, file 5b38ade5-0d36-4383-b9c3-01953be11c0d 5
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients., file e27ce426-f50a-2581-e053-d805fe0acbaa 5
Differential impact of individual autonomic domains on clinical outcomes in Parkinson's disease, file 76cc6326-dedf-4651-b0ec-43d0083bcd7e 4
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome?, file e27ce426-fa3c-2581-e053-d805fe0acbaa 4
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response?, file e27ce429-c3a9-2581-e053-d805fe0acbaa 4
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease, file e27ce42a-e418-2581-e053-d805fe0acbaa 4
Beyond 35 years of Parkinson’s disease: a comprehensive clinical and instrumental assessment, file e27ce42d-2bae-2581-e053-d805fe0acbaa 4
Machine learning applied to ambulatory blood pressure monitoring: a new tool to diagnose autonomic failure?, file e27ce434-dd44-2581-e053-d805fe0acbaa 4
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease?, file e27ce426-f5b8-2581-e053-d805fe0acbaa 3
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience, file e27ce426-fc97-2581-e053-d805fe0acbaa 3
Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study, file e27ce427-a4d3-2581-e053-d805fe0acbaa 3
Parkinsonism–hyperpyrexia syndrome and deep brain stimulation, file e27ce428-34b3-2581-e053-d805fe0acbaa 3
Comparison of subthalamic nucleus Deep Brain Stimulation and Duodopa in the treatment of advanced Parkinson's disease., file e27ce428-44af-2581-e053-d805fe0acbaa 3
Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation?, file e27ce428-46e0-2581-e053-d805fe0acbaa 3
Reply to: "Autonomic dysfunction in Parkinson's disease: The hidden game changer?", file e27ce42c-d018-2581-e053-d805fe0acbaa 3
Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside, file e27ce42d-8c1c-2581-e053-d805fe0acbaa 3
Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: A long-term prospective assessment, file e27ce432-5158-2581-e053-d805fe0acbaa 3
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset?, file e27ce426-dbf4-2581-e053-d805fe0acbaa 2
Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients, file e27ce426-fafa-2581-e053-d805fe0acbaa 2
Advanced therapies in Parkinson's disease: Long-term retrospective study, file e27ce429-ba37-2581-e053-d805fe0acbaa 2
Adaptive deep brain stimulation controls levodopa-induced side effects in Parkinsonian patients, file e27ce42c-64de-2581-e053-d805fe0acbaa 2
Orthostatic hypotension and REM sleep behaviour disorder: Impact on clinical outcomes in α-synucleinopathies, file e27ce42e-90fa-2581-e053-d805fe0acbaa 2
Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study., file e27ce426-d9a7-2581-e053-d805fe0acbaa 1
Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease, file e27ce426-e3c0-2581-e053-d805fe0acbaa 1
Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study, file e27ce426-f7a9-2581-e053-d805fe0acbaa 1
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study., file e27ce427-0f2c-2581-e053-d805fe0acbaa 1
Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients., file e27ce428-4c91-2581-e053-d805fe0acbaa 1
Subcutaneous vs. intravenous immunoglobulin in CIDP: pharmacokinetic and clinical response, file e27ce429-be72-2581-e053-d805fe0acbaa 1
Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases, file e27ce42c-61b6-2581-e053-d805fe0acbaa 1
Subthalamic deep brain stimulation and levodopa in Parkinson’s disease: a meta-analysis of combined effects, file e27ce42d-2bac-2581-e053-d805fe0acbaa 1
Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study, file e27ce42d-3ef9-2581-e053-d805fe0acbaa 1
Telemedicine in Neurological Disorders: Opportunities and Challenges, file e27ce42d-53b7-2581-e053-d805fe0acbaa 1
Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study, file e27ce42d-972c-2581-e053-d805fe0acbaa 1
Levodopa-Induced Neuropathy: A Systematic Review, file e27ce42e-8281-2581-e053-d805fe0acbaa 1
Orthostatic hypotension and REM sleep behaviour disorder: Impact on clinical outcomes in α-synucleinopathies, file e27ce432-5157-2581-e053-d805fe0acbaa 1
Effect of subthalamic deep brain stimulation on posture in Parkinson's disease: A blind computerized analysis, file e27ce432-571f-2581-e053-d805fe0acbaa 1
Functional neurological disorders in Parkinson disease, file e27ce432-5721-2581-e053-d805fe0acbaa 1
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response?, file e27ce432-5906-2581-e053-d805fe0acbaa 1
Adaptive deep brain stimulation controls levodopa-induced side effects in Parkinsonian patients, file e27ce432-617c-2581-e053-d805fe0acbaa 1
Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases, file e27ce432-617d-2581-e053-d805fe0acbaa 1
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders, file e27ce432-80f2-2581-e053-d805fe0acbaa 1
Totale 4.480
Categoria #
all - tutte 5.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.502


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019207 0 0 0 0 0 0 0 0 0 56 83 68
2019/2020714 56 41 48 77 65 40 51 56 82 65 77 56
2020/2021829 58 115 98 57 61 64 61 64 62 75 59 55
2021/2022714 64 45 48 101 80 44 53 49 49 48 89 44
2022/2023608 26 46 93 78 58 39 71 66 56 53 21 1
2023/202420 0 2 4 1 2 2 5 3 0 1 0 0
Totale 4.480